Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2019-03-21 Director's Dealing
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a formal notification regarding transactions by company directors and executives (insiders) involving share options and performance shares. It explicitly references Article 19 of the EU Market Abuse Regulation (MAR), which is the standard regulatory framework for reporting director dealings. The content lists specific names, positions, and the nature of the transactions, which aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2019-03-21 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a notification of transactions by persons discharging managerial responsibilities (PDMRs) at ALK-Abelló A/S, specifically regarding the allocation of share options and performance shares. This falls under the category of 'Director's Dealing' (DIRS), as it reports personal share-related transactions by company executives as required by the EU Market Abuse Regulation (MAR).
2019-03-21 English
Remuneration Information 2019
Remuneration Information Classification · 99% confidence The document explicitly details the granting of share options and performance shares to the Board of Management and key employees, referencing incentive payment guidelines adopted at an annual general meeting. This type of announcement concerns executive compensation and insider transactions related to equity awards. While it involves management (MANG) and could be considered a type of capital change (SHA/CAP), the most specific category for reporting compensation details, especially for directors/management, is Remuneration Information (DEF 14A). However, DEF 14A is typically a proxy statement detailing *existing* remuneration policy and historical pay. This document is a specific, immediate announcement about the *grant* of new options/shares. Since it details compensation/incentives for management, and is not a standard 10-K/IR, it fits best under a category related to management or capital structure. Given the focus on executive incentives and grants, it is closely related to management decisions. If we strictly follow the provided definitions, 'DEF 14A' is for Remuneration Information, which covers compensation for top executives. This announcement is a direct report on executive compensation grants. Alternatively, since it involves transactions by insiders (management), it touches upon DIRS, but DIRS is usually for personal share transactions, not option grants announced by the company. Given the context of incentive plans for management, DEF 14A is the closest fit for executive remuneration disclosure, even if it's an announcement rather than the full proxy statement.
2019-03-21 English
Remuneration Information 2019
Remuneration Information Classification · 99% confidence The document text details the allocation ('Tildeling') of stock options ('aktieoptioner') and performance shares ('performance-aktier') to senior management and key employees, referencing guidelines from a general meeting and specifying valuation methods (Black & Scholes) and vesting conditions. This content directly relates to executive and employee compensation and incentives, which falls under Remuneration Information. The closest matching category is DEF 14A (Remuneration Information), which covers compensation for top executives and directors. Although this is not a formal DEF 14A filing document itself, the subject matter is remuneration disclosure.
2019-03-21 Danish
Grant of share options and performance shares to members of the Board of Management and key employees
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the allocation of stock options and performance shares to the management and key employees of ALK-Abelló A/S. While it details remuneration, it is a short announcement (under 5,000 characters) that explicitly includes a link to an attached file ('Vedhæftet fil'). According to the 'Menu vs Meal' rule, documents that announce the publication of a report or provide a link to an attached file are classified as Report Publication Announcements (RPA).
2019-03-21 English
Grant of share options and performance shares to members of the Board of Management and key employees
Regulatory Filings Classification · 85% confidence The document is a company release detailing the grant of share options and performance shares to the Board of Management and key employees. While it discusses remuneration, it is a specific announcement of an incentive program grant rather than a comprehensive proxy statement (DEF 14A) or a director's personal dealing report (DIRS). Since it describes the issuance of equity-based compensation instruments, it falls under the category of share-related capital changes or incentive announcements. Given the specific nature of the grant, it is best classified as a regulatory filing (RNS) as it does not fit perfectly into the narrow definitions of DIRS or DEF 14A.
2019-03-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.